{{ .infobox .infobox-gene }}
Lifr Leukemia Inhibitory Factor Receptor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
LIFR (Leukemia Inhibitory Factor Receptor) is a cytokine receptor that transduces signals from leukemia inhibitory factor (LIF) and related cytokines. It plays crucial roles in neural development, stem cell maintenance, and neuroprotection. The LIFR is essential for mediating the neuroprotective effects of the LIF cytokine family in the central nervous system.
LIFR forms a signaling complex with gp130 (IL6ST):
LIF binding to LIFR triggers:
LIFR signaling interacts with:
LIFR signaling has significant therapeutic potential in ALS:
LIFR contributes to dopaminergic neuron survival:
LIFR has therapeutic potential in MS:
LIFR signaling is neuroprotective:
LIF signaling may have beneficial effects:
Therapeutic strategies targeting LIFR:
LIF has been evaluated in clinical trials for ALS and other conditions.
Current research focuses on:
The study of Lifr Leukemia Inhibitory Factor Receptor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.